Walnut Creek, California Clinical Trials

A listing of Walnut Creek, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 210 clinical trials
High-dose Vitamin D Supplements in Older Adults

This Phase II randomized clinical trial aims to test if supplementation with high dose oral vitamin D will successfully correct vitamin D insufficiency, compared to treatment with standard (RDA) dose vitamin D in a diverse community-based elderly cohort. The effect of high-dose vs. standard-dose vitamin D on altering cognitive trajectories …

University of California, Davis Alzheimer's Disease Center
 (4.7 away) Contact site
  • 0 views
  • 23 Nov, 2020
  • 1 location
Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy and safety of intramuscular (IM) administration of Engensis on pain in participants with painful diabetic peripheral neuropathy (DPN) in the feet and lower legs, as compared to Placebo, as a second Phase 3, well controlled study, sufficient in supporting the …

Diablo Clinical Research
 (2.2 away) Contact site
  • 0 views
  • 20 Nov, 2020
  • +4 other locations
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

This randomized phase III trial studies how well imatinib mesylate and combination chemotherapy work in treating patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia. Imatinib mesylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, work …

leukemia
cyclophosphamide
glomerular filtration rate
imatinib
pegaspargase
Kaiser Permanente-Oakland
 (9.2 away) Contact site
  • 305 views
  • 29 Nov, 2020
  • +171 other locations
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors.

tumor cells
central pathology review
ct scan
step 2
intracranial meningioma
Kaiser Permanente Oakland-Broadway
 (9.6 away) Contact site
  • 803 views
  • 11 Oct, 2020
  • +179 other locations
S0820 Adenoma and Second Primary Prevention Trial

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon or rectal cancer.

aspirin
unstable angina
adenoma
rectal carcinoma
anticoagulants
Kaiser Permanente-Walnut Creek
 (0.7 away) Contact site
  • 2518 views
  • 26 Nov, 2020
  • +1023 other locations
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

This randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to capecitabine in treating patients with remaining (residual) basal-like triple-negative breast cancer following chemotherapy after surgery (neoadjuvant). Drugs used in chemotherapy, such as cisplatin, carboplatin and capecitabine, work in different ways to stop the …

ductal carcinoma
lobular carcinoma
international normalized ratio
erbb2
capecitabine
Epic Care Cyberknife Center
 (0.7 away) Contact site
  • 508 views
  • 27 May, 2020
  • +702 other locations
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

This randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer. Drugs used in chemotherapy, such as doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, …

ductal carcinoma
absolute neutrophil count
cyclophosphamide
erbb2
pet/ct scan
Kaiser Permanente-Walnut Creek
 (0.7 away) Contact site
  • 814 views
  • 05 Aug, 2019
  • +810 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

ulixertinib
combinations
absolute neutrophil count
dasatinib
chemotherapy regimen
Kaiser Permanente-Walnut Creek
 (0.7 away) Contact site
  • 6087 views
  • 29 Nov, 2020
  • +967 other locations
Apixaban for the Acute Treatment of Venous Thromboembolism in Children

To assess the safety and descriptive efficacy of apixaban in pediatric subjects requiring anticoagulation for the treatment of a VTE.

heparin
venous thromboembolism
anticoagulation therapy
vitamin k
apixaban
Kaiser Permanente-Oakland c/o Kris Nishimura, Pharm. D
 (9.6 away) Contact site
  • 0 views
  • 23 Nov, 2020
  • +160 other locations
Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

This trial will evaluate the efficacy and safety of combination of pomalidomide (POM) and low-dose dexamethasone (LD-Dex) (Cohort A) or the combination of pomalidomide (POM) , daratumumab (DARA) and low-dose dexamethasone (LD-Dex) (Cohort B) in subjects with relapsed or refractory multiple myeloma who have received a first or second line …

measurable disease
dexamethasone
vasectomy
refractory multiple myeloma
lenalidomide
Bay Area Cancer Research Group, LLC
 (3.1 away) Contact site
  • 79 views
  • 16 Apr, 2020
  • +47 other locations